This study is completed in the United States. It is testing BXCL501 Evaluated for schizophrenia.
Bipolarity, Schizophrenia, ...DrugFrom 18 Years to 75 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether BXCL501 Evaluated may be useful for adults experiencing bipolarity.
What would participation involve?
Participants may receive BXCL501 Evaluated, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for adults with bipolarity.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: November 21, 2022
Recruitment status
Completed
Enrollment listed in the registry
452
Sponsor
BioXcel Therapeutics Inc
Sponsor type
Biotech company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT05658510
Official title
Efficacy And Safety of BXCL501 Evaluated For At-Home Use In A Multisite Double-Blind Placebo-Controlled Trial For Agitation Associated With Schizophrenia And Bipolar Disorder
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT05658510. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 24 sites
BioXcel Clinical Research Site 113
Bellflower, California
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 128
Cerritos, California
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 110
Culver City, California
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 108
Garden Grove, California
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 117
Lemon Grove, California
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 121
Los Angeles, California
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 123
Oceanside, California
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 104
Orange, California
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 133
Rancho Cucamonga, California
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 114
Riverside, California
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 129
Denver, Colorado
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 131
Miami, Florida
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 124
Miami, Florida
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 130
Elgin, Illinois
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 103
Gaithersburg, Maryland
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 118
Las Vegas, Nevada
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 137
Las Vegas, Nevada
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 105
Berlin, New Jersey
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 122
Beachwood, Ohio
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 136
Austin, Texas
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 102
DeSoto, Texas
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 125
Irving, Texas
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 127
Plano, Texas
Site status: Not listed — confirm with the team
BioXcel Clinical Research Site 126
Everett, Washington
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving BXCL501, Matching Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with bipolarity; age range: From 18 Years to 75 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by BioXcel Therapeutics Inc, which appears to be a biotech company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
